Press Releases

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead

BIOTRONIK Receives FDA Approval for Solia CSP S, World’s First Pacing Lead Specifically Designed For LBBAP

Solia CSP S pacing lead has received approval from the U.S. Food and Drug Administration (FDA)

Boston Scientific Advisory Regarding the Potential for Shock Coil Calcification and Reduced Shock Efficacy for RELIANCE G Defibrillation Leads with Gore ePTFE Coated Shock Coils Manufactured Between 2002 and 2021

Certain defibrillation leads may put patients at risk due to calcification

Late-Breaking Clinical Trials at Heart Rhythm 2025 Showcase Promising Outcomes for Left Bundle Branch Area Pacing in Heart Failure Treatment

Findings from two late-breaking clinical trials demonstrate the safety and efficacy of left bundle branch area pacing (LBBAP), adding to the growing body of evidence supporting new pacing methods. Researchers presented these findings as late-breaking clinical science today during Heart Rhythm 2025.

BIOTRONIK Receives FDA Approval for LBBAP Indication on Pacing Lead and Delivery Catheter System